Joseph D. Keegan, CEO/President at MOLECULAR DEVICES CORP (MDCC), sold 34,000 shares at $32.45 ($1.1M) on 2006-02-21, disclosed to the SEC on 2006-02-22.
Open-market sale of $1.1M MDCC by CEO/President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.42 | 6,000 | $189K | 17.3% |
| 2 | $31.89 | 13,000 | $415K | 38.0% |
| 3 | $32.45 | 1,000 | $32K | 3.0% |
| 4 | $32.45 | 9,000 | $292K | 26.8% |
| 5 | $32.75 | 5,000 | $164K | 15.0% |
| Total | $32.10 avg | 34,000 |
| $1.1M |
| 100% |
| Filing → |
| MDCC | SELL | 2006-02-17 | $158K | — | Filing → |
| MDCC | SELL | 2006-02-14 | $289K | — | Filing → |
| MDCC | SELL | 2006-02-14 | $155K | — | Filing → |